PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 116 |
| PubMedID- 24423050 | The gstt1-null genotype and combined gstt1*0/gstm1*0 might be potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus [16]. |
| PubMedID- 25889178 | In selected populations, such as patient with type 2 diabetes, the role of uric acid in atherosclerosis might be the result of other concomitant atherosclerotic risk factors, such as ckd. |
| PubMedID- 20005514 | Wide postchallenge glucose excursions may contribute to the development of atherosclerosis in individuals with type 2 diabetes, independent of other risk factors. |
| PubMedID- 22330623 | The gstt1-0 genotype and gstt1-0/gstm1-0 haplotype might be a potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 25959788 | Aims: we examined the association between hemoglobin a1c (hba1c) variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes. |
| PubMedID- 26047614 | Multiple logistic regression analysis further showed that serum fgf21 was an independent impact factor for subclinical atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 25975128 | [a relationship between cardiac structural and functional parameters, left ventricular contractility, and coronary atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 24373412 | Therefore, a cca-imt of 1.1 mm is usually accepted as a cut-off value for the presence of carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20701448 | An update on markers of carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 23342952 | Prospective studies are needed to assess the time course and relevance of serum osteocalcin in the development of atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 21894292 | Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. |
| PubMedID- 25370328 | Objective: we investigated the correlation between the severity of diabetic retinopathy (dr) and carotid intima media thickness (imt) as a marker of atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 21775758 | Objective: to investigate whether waist circumference (wc), calf circumference (cc), and waist-to-calf ratio (wcr) are associated with carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 24988089 | This might be one of the causal pathogenic factors initiating accelerated atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 23711224 | The study demonstrated that neat is associated with amelioration in insulin sensitivity, waist circumference, high-density lipoprotein-cholesterol, blood pressure and the marker for atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 22103619 | Aim: the aim of this study was to evaluate the association between the circulating bmp-4 levels and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 22525426 | These studies suggest that hyperinsulinemia could promote macrophage foam cell formation and thus may contribute to atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 21816063 | Conclusions: serum uric acid level is associated with mets and is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 26260869 | This finding suggested that plasma opg levels were an important determinant of lower extremity arterial atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 23570342 | Another new marker that deserves our attention is the uric acid; although uric acid can act as an antioxidant, excess serum accumulation is often associated with several conditions, and has been suggested as an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes [25]. |
| PubMedID- 24966876 | Reduction of als by rsg increases the risk of atherosclerosis in individuals with type 2 diabetes. |
| PubMedID- 24599017 | The aim of this study was to assess whether the iad could be a marker for subclinical atherosclerosis in patients with type 2 diabetes who are at high risk of cardiovascular disease (cvd). |
| PubMedID- 24560424 | Association of reduced levels of serum 1,5-anhydro-d-glucitol with carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 21129801 | Conclusions: this study shows that diabetic retinopathy is an independent risk marker for subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. |
| PubMedID- 24334868 | Background: to our knowledge there has been no study investigating the impact of freeze-dried strawberry (fds) supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes (t2d). |
| PubMedID- 22011410 | Conclusions: our results suggest that esrage may be a potential protective factor for dyslipidemia, atherosclerosis, and mci in patients with type 2 diabetes. |
| PubMedID- 25405332 | Our findings strongly suggest that, in select populations such as those with type 2 diabetes, the role of uric acid in atherosclerosis might be attributable to other cardiovascular risk factors, such as htn and mets. |
| PubMedID- 22100253 | The aim of this study was to investigate the relationship between the variability in sbp and the degree of diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 25369080 | Background: the genetic background of atherosclerosis in type 2 diabetes mellitus (t2dm) is complex and poorly understood. |
| PubMedID- 20207378 | [usefulness of pulse oximetry in screening of carotid atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 24396666 | One recent study showed that glucose variability for 72 hours measured by a continuous glucose monitoring system was associated with coronary atherosclerosis in patients with type 2 diabetes [17]. |
| PubMedID- 19834878 | Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 24678948 | The aim of this study was to investigate the relationships of subcutaneous and visceral abdominal fat with carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 20617078 | Our study demonstrates that long-term glucose variability, measured by a1c variability, has no significant influence on the progression of carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20302618 | Varghese performed a randomized, placebo-controlled, double-blind study to evaluate the effect of rosiglitazone treatment on carotid atherosclerosis in subjects with type 2 diabetes with a primary endpoint of the change from baseline in carotid arterial wall volume, reflecting plaque burden, as measured by cmr [66]. |
| PubMedID- 24741463 | Response: association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes (endocrinol metab 2013;28:309-19, chan-hee jung et al.). |
| PubMedID- 25794984 | Therefore, this study will be performed to evaluate the effects of sitagliptin, a dpp-4 inhibitor, on coronary atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 25889082 | Conclusions: serum angptl2 concentration was significantly and positively associated with carotid atherosclerosis in patients with type 2 diabetes, suggesting that angptl2 may be important in the atherosclerosis in humans. |
| PubMedID- 24373894 | Conclusions: the mean-ptg concentration is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 26445876 | This study was designed to elucidate whether high visceral fat with low subcutaneous fat accumulation enhances the risk for atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 26399335 | In conclusion, af might be a beneficial surrogate marker for evaluating carotid atherosclerosis in patients with type 2 diabetes non-invasively. |
| PubMedID- 20004424 | We investigated the relationship between hemoglobin concentration and various factors as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus. |
| PubMedID- 21779189 | Recently, 2 adipocytokines, leptin and adiponectin, have been recognized as key regulators of various metabolic disorders, and the serum/plasma leptin:adiponectin ratio (l:a) has been reported to be a new surrogate marker for atherosclerosis in subjects with obesity and type 2 diabetes mellitus [6, 7]. |
| PubMedID- 26064988 | In conclusion, the fmd is considered to be useful for the detection of atherosclerosis in patients with type 2 diabetes, even if overt macroangiopathy is not diagnosed. |
| PubMedID- 22234513 | In conclusion, nt-probnp could be a marker of subclinical atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 24741462 | Letter: association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes (endocrinol metab 2013;28:309-19, chan-hee jung et al.). |
| PubMedID- 24349318 | In this report, we explore the possibility of urinary mir-29 family as biomarker for diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 26162315 | In selected populations, such as those with type 2 diabetes, the role of uric acid in atherosclerosis may be result from other concomitantly atherosclerotic risk factors, such as dr. |
| PubMedID- 25120969 | Effect of age and blood pressure on surrogate markers of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 20414371 | To date, the mcp-1 –2518 a>g polymorphism has been associated with coronary artery disease, nonfamilial idiopathic dilated cardiomyopathy, carotid atherosclerosis in patients with type 2 diabetes, myocardial infarction, ischemic heart disease, and hypertension [33–38]. |